LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis
出版年份 2020 全文链接
标题
LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis
作者
关键词
-
出版物
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-09-23
DOI
10.1007/s11010-020-03904-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- ZEB1 mediates doxorubicin (Dox) resistance and mesenchymal characteristics of hepatocarcinoma cells
- (2019) Lin Long et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Knockdown of lncRNA‑HOTAIR downregulates the drug‑resistance of breast cancer cells to doxorubicin via the PI3K/AKT/mTOR signaling pathway
- (2019) Zhixiang Li et al. Experimental and Therapeutic Medicine
- MALAT1 functions as a competing endogenous RNA to regulate SMAD5 expression by acting as a sponge for miR-142-3p in hepatocellular carcinoma
- (2019) Qiangfeng Yu et al. Cell and Bioscience
- LncRNA-MALAT1 contributes to the cisplatin-resistance of lung cancer by upregulating MRP1 and MDR1 via STAT3 activation
- (2018) Zhixian Fang et al. BIOMEDICINE & PHARMACOTHERAPY
- Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
- (2018) Omar Massoud et al. Clinics in Liver Disease
- Knockdown of MALAT1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway
- (2018) Lin Bai et al. EXPERIMENTAL CELL RESEARCH
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1
- (2018) Lingjiang Jin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Unknown
- (2017) Experimental and Clinical Transplantation
- Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer
- (2017) Wanli Yang et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Nova1 mediates resistance of rat pheochromocytoma cells to hypoxia-induced apoptosis via the Bax/Bcl-2/caspase-3 pathway
- (2017) Hualing Li et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Down-regulation of the long noncoding RNA-HOX transcript antisense intergenic RNA inhibits the occurrence and progression of glioma
- (2017) Bin Yang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer
- (2017) Hu YiRen et al. Molecular Cancer
- MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2
- (2017) Peilong Li et al. MOLECULAR CANCER THERAPEUTICS
- The long noncoding RNA Malat1: Its physiological and pathophysiological functions
- (2017) Xuejing Zhang et al. RNA Biology
- The diagnosis and treatment of hepatocellular carcinoma
- (2017) Justin Hartke et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world
- (2017) Dimitrios Dimitroulis et al. WORLD JOURNAL OF GASTROENTEROLOGY
- LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194
- (2017) Jihong An et al. OncoTargets and Therapy
- MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy
- (2017) Fangfang Jin et al. Cell Death & Disease
- LncRNA H19 is a major mediator of doxorubicin chemoresistance in breast cancer cells through a cullin4A-MDR1 pathway
- (2017) Qiong-Ni Zhu et al. Oncotarget
- Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer
- (2017) Wanli Yang et al. Expert Review of Gastroenterology & Hepatology
- Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis
- (2016) Andrea Marengo et al. Annual Review of Medicine
- The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy
- (2016) Peng Yuan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Long non-coding RNAs in cancer drug resistance development
- (2016) Maryam Majidinia et al. DNA REPAIR
- Implications of NOVA1 suppression within the microenvironment of gastric cancer: association with immune cell dysregulation
- (2016) Eun Kyung Kim et al. Gastric Cancer
- MicroRNA-induced drug resistance in gastric cancer
- (2015) Rashedeh Dehghanzadeh et al. BIOMEDICINE & PHARMACOTHERAPY
- MicroRNA-339, an epigenetic modulating target is involved in human gastric carcinogenesis through targeting NOVA1
- (2015) Bo Shen et al. FEBS LETTERS
- Role of miR-155 in drug resistance of breast cancer
- (2015) Dan-dan Yu et al. TUMOR BIOLOGY
- LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer
- (2015) Sheng-Jia Shi et al. Oncotarget
- High Expression of Neuro-Oncological Ventral Antigen 1 Correlates with Poor Prognosis in Hepatocellular Carcinoma
- (2014) Yi-An Zhang et al. PLoS One
- MiR-181b-5p Downregulates NOVA1 to Suppress Proliferation, Migration and Invasion and Promote Apoptosis in Astrocytoma
- (2014) Feng Zhi et al. PLoS One
- Drug resistance-related miRNAs in hepatocellular cancer
- (2014) Liu Hong et al. Expert Review of Gastroenterology & Hepatology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started